SBI Contra Fund drops 0.60% to ₹412.68; TREPS holds 9.76% weight
Last Updated: 8th September 2026 - 11:16 am
Key Takeaways
- The fund closed at ₹412.68, down 0.60%.
- The one-year return was -0.25%.
- TREPS was the biggest disclosed allocation at 9.76%.
- The five-year annualised return stood at 15.73%.
SBI Contra Fund Direct Growth closed at ₹412.68 on 7 September 2026. It fell 0.60% during the latest valuation period.
The one-year return was slightly negative at -0.25%. Over three years, the annualised return stood at 11.21%. The five-year figure was 15.73%.
TREPS occupied 9.76% of the disclosed portfolio and was the largest allocation. Reliance Industries followed at 4.80%.
HDFC Bank made up 4.72%, ICICI Bank 4.43% and Biocon 3.53%. Taken together, these five allocations represented 27.24%.
The fund size stood at ₹48,266 crore.
SBI Contra Fund's risk figures included an alpha of 6.34 and beta of 0.98. Standard deviation was 4.06 and the Sharpe ratio was 0.55.
The expense ratio for the Direct Growth plan stood at 0.86%.
A minimum SIP required ₹500. The minimum lump-sum investment was ₹5,000.
The exit-load window was shorter than the one-year structure used by several equity funds. Redemption within 30 days attracts a 0.25% load. After 30 days and up to 90 days, the load drops to 0.10%. There is no exit load after 90 days.
The difference between the three- and five-year return figures was 4.52 percentage points. That was a much larger gap than the day's 0.60% NAV movement, though the two numbers cover entirely different periods.
On the portfolio side, TREPS was more than twice as large as any individual equity holding in the disclosed top positions.
Frequently Asked Questions
What was SBI Contra Fund Direct Growth's NAV?
What were its three-year and five-year returns?
How much was held in TREPS?
What was the fund size?
- 0 Transaction Cost
- Curated Fund Lists
- 4000+ MF Schemes
- Start SIP with Ease
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.
5paisa Capital Ltd